262 related articles for article (PubMed ID: 8914680)
21. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells.
Pallesen G; Sandvej K; Hamilton-Dutoit SJ; Rowe M; Young LS
Blood; 1991 Sep; 78(5):1162-5. PubMed ID: 1652308
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
23. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease.
van Gorp J; Jacobse KC; Broekhuizen R; Alers J; van den Tweel JG; de Weger RA
J Clin Pathol; 1994 Jan; 47(1):29-32. PubMed ID: 8132805
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
[TBL] [Abstract][Full Text] [Related]
25. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
[TBL] [Abstract][Full Text] [Related]
26. The association between Epstein-Barr virus and Chinese Hodgkin's disease.
Zhou XG; Hamilton-Dutoit SJ; Yan QH; Pallesen G
Int J Cancer; 1993 Sep; 55(3):359-63. PubMed ID: 8397160
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease.
Herndier BG; Sanchez HC; Chang KL; Chen YY; Weiss LM
Am J Pathol; 1993 Apr; 142(4):1073-9. PubMed ID: 8386441
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
[TBL] [Abstract][Full Text] [Related]
29. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
30. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Reynolds DJ; Banks PM; Gulley ML
Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
[TBL] [Abstract][Full Text] [Related]
31. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R
Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848
[TBL] [Abstract][Full Text] [Related]
33. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
34. [Presence of human cytomegalovirus within the neoplastic cells of Hodgkin's disease].
Huang GS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):403-5. PubMed ID: 12940088
[TBL] [Abstract][Full Text] [Related]
35. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
36. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
[TBL] [Abstract][Full Text] [Related]
37. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.
Claviez A; Tiemann M; Peters J; Kreipe H; Schneppenheim R; Parwaresch R
Ann Hematol; 1994 Feb; 68(2):61-6. PubMed ID: 8148417
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells.
Naresh KN; Johnson J; Srinivas V; Soman CS; Saikia T; Advani SH; Badwe RA; Dinshaw KA; Muckaden M; Magrath I; Bhatia K
Ann Oncol; 2000 Jan; 11(1):91-6. PubMed ID: 10690394
[TBL] [Abstract][Full Text] [Related]
39. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
40. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
